(Q46217603)

20 December 2017

title

Effects of beta blockers on symptoms and functional capacity in heart failure (English)

1 reference

20 December 2017

author name string

M B Fowler

series ordinal

1

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

20 December 2017

American Journal of Cardiology

published in

1 reference

20 December 2017

volume

80

1 reference

20 December 2017

issue

11A

1 reference

20 December 2017

page(s)

55L-58L

1 reference

20 December 2017

Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Rationale for beta-adrenergic blocking drugs in cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900849-7

10.1016/S0002-9149(97)00849-7

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

release_fgte5oyfvnd7fmk2kxjnf6djsi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fgte5oyfvnd7fmk2kxjnf6djsi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

20 December 2017